Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02997839 · ClinicalTrials.gov registry record · NA

Sleep Disruption in Post-operative Patients in the Neurocritical Care Unit

A NA study, sponsored by Johns Hopkins University.

Terminated
Registry status
NA
Development phase
1
Enrollment target

NCT02997839: Clinical Trial NA study, sponsored by Johns Hopkins University.

NCT02997839 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02997839, a NA study, was terminated before completion, sponsored by Johns Hopkins University.

TERMINATED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

The role of sleep in patients admitted to the intensive care unit is an emerging field of research. There have been studies that show patients in the ICU have poor sleep including sleep fragmentation, multiple arousals, decreased stage 3 sleep and reduced REM sleep (1, 2, 3). Causes of poor sleep in the ICU include severity of illness, abnormal light exposure, and frequent arousals for medical care. Not only does poor sleep contribute to reduced cognitive function and delirium, but there are also implications for the immune system function and wound healing (4). Polysomnography is regarded as the gold standard for sleep studies, however it has limited utility in the ICU population (5) and alternative methods of sleep analysis need to be investigated to better understand the underlying physiologic mechanisms and subsequent cognitive effects.

Primary Outcome

The investigators will use an automated EEG detection system used in patients with continuous EEG (cEEG) monitoring to detect duration of sleep related EEG brain activity, number of intervals of activation, and the duration of the intervals for sleep activities including: REM, Stage 1, stage 2, and stage 3 sleep, sleep spindles, and alpha activity.

Interventions

  • BEHAVIORAL sleep disruption

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2016-12
Est. Completion 2018-03-26
Phase NA
Johns Hopkins University

1,448 total trials

Why NCT02997839 stopped before completion

NCT02997839 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which sleep disruption is the first listed.

NCT02997839 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02997839 about?

NCT02997839 is a clinical study titled "Sleep Disruption in Post-operative Patients in the Neurocritical Care Unit". The role of sleep in patients admitted to the intensive care unit is an emerging field of research. There have been studies that show patients in the ICU have poor sleep including sleep fragmentation, multiple arousals, decreased stage 3 sleep and reduced REM sleep (1, 2, 3). Causes of poor sleep in...

What is the current status of trial NCT02997839?

This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2016-12. Estimated completion is 2018-03-26.

What interventions are being tested in trial NCT02997839?

The interventions under investigation include: sleep disruption (BEHAVIORAL).

Who is sponsoring clinical trial NCT02997839?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02997839's enrollment target sits among peer trials

1 2001st of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02997839, the US trial registry maintained by the National Library of Medicine. NCT02997839 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.